Ignite Creation Date:
2024-05-06 @ 1:47 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04126005
Status:
RECRUITING
Last Update Posted:
2023-07-12
First Post:
2019-10-10
Brief Title:
Natural History Study of Patients With Canavan Disease CANinform Study
Sponsor:
Aspa Therapeutics
Organization:
Aspa Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Canavan Disease |
Keywords:
| Name | View |
|---|---|
| Neurodevelopmental diseases | View |
| Canavan Disease | View |
| AAV | View |
| AAV9 | View |
| Gene therapy | View |
| Aspartoacylase | View |
| ASPA | View |
| ASPA gene | View |
| rAAV9 | View |
| ACY2 | View |
| Aminoacylase 2 | View |
| Spongy degeneration | View |
| N-acetyl-L-aspartic acid NAA | View |
| N-acetylaspartate | View |
| Rare disease | View |
| Inherited Metabolic Disorders | View |
| Leukodystrophy | View |
| Leukoencephalopathies | View |
| Autosomal Recessive Disorder | View |